BRADYCARDIA

This study is testing a new type of pacemaker lead (Solia CSP S) that is placed deep in the heart's natural electrical system to help people with slow heartbeats. About 192 participants will get this lead, and researchers will check for serious side effects within 3 months and ho…

This study tests the safety and performance of a new pacemaker (Amvia) and a special lead (Solia CSP S) designed to pace the heart's natural electrical system more precisely. It involves 152 people who need a pacemaker or cardiac resynchronization therapy. Participants are follow…

This study is testing a new type of pacemaker that doesn't use wires (leads) to help control slow heartbeats. About 20 adults who need a pacemaker will get this device and be checked for safety and performance at 1 and 3 months. The goal is to see if the device works well and cau…

This study follows about 37,000 Medicare patients who received a Micra leadless pacemaker to treat slow heart rate (bradycardia). Researchers use insurance claims to check for complications within 30 days and survival rates over two years. The goal is to gather real-world safety …

This study gathers information from 1,000 adults with heart rhythm problems like bradycardia or tachycardia who already have or are getting a cardiac implantable device. Researchers will look at device details, implant procedures, and patient characteristics to guide the developm…

This study is a registry that follows about 3,100 people who receive a Micra pacemaker for slow heart rate (bradycardia). The goal is to confirm the device works safely and effectively in routine medical practice after it has been approved. Participants are observed for complicat…